Theodore Lundberg Acquires Shares in AdaptHealth Corp.

Theodore Lundberg, an insider at AdaptHealth Corp. (NasdaqCM: AHCO), purchased 18,999 shares of the company on June 24, 2026. This transaction is part of a broader trend of insider buying at the healthcare equipment distributor.

Insider Buying and Selling at AdaptHealth Corp.

Several insiders, including Theodore Lundberg, David Solomon Williams III, and Bradley Coppens, each acquired 18,999 shares of AdaptHealth Corp. on June 24, 2026. These purchases were not made under a Rule 10b5-1 plan, indicating they were discretionary buys rather than pre-scheduled transactions.

Other Institutional Activity in AdaptHealth Corp.

Institutional investors have also shown interest in AdaptHealth Corp. OEP Capital Advisors, L.P. added 2,494,518 shares, bringing its total to 16,312,698 shares worth about $194.1 million, marking an 18.1% increase. BlackRock, Inc. increased its position by 247,939 shares to a total of 15,939,953 shares valued at approximately $189.7 million, reflecting a 1.6% increase. Meanwhile, Reinhart Partners, LLC. boosted its stake by 1,981,198 shares, ending with 10,081,983 shares worth around $120 million, a 24.5% increase.

AdaptHealth Corp. Stock Up 77.7%

Shares of AdaptHealth Corp. traded near $10.18 on Saturday. The company, with a market cap of about $1.4 billion, has a forward P/E ratio of 8.8 and a beta of 1.463. Over the past year, the stock has ranged from $8.51 to $13.43. Its 50-day moving average is $10.99, while the 200-day average is $10.21. The company has a current ratio of 0.925 and a quick ratio of 0.614, with a debt-to-equity ratio of 132.1.

Recent Earnings

AdaptHealth Corp. reported revenue of approximately $3.29 billion, with a growth rate of 5.4%. However, the company posted a net margin of -2.4% and a return on equity of -4.8%, indicating challenges in profitability. The next earnings report is expected on August 4, 2026.

Analysts Set New Price Targets

Analysts maintain a positive outlook on AdaptHealth Corp. RBC Capital maintained a 'buy' rating with a $15 target on May 11, 2026. Canaccord Genuity also kept its 'buy' rating with a $16 target on May 6, 2026. The consensus among eight analysts is a 'buy' recommendation, with a mean target price of $14.

About AdaptHealth Corp.

AdaptHealth Corp. is a healthcare company based in Conshohocken, Pennsylvania. It provides home medical equipment and services across the U.S., focusing on sleep therapy, respiratory health, diabetes management, and home wellness. The company serves patients through Medicare, Medicaid, and commercial insurance payors. Suzanne M. Foster, M.P.H., leads the company, which employs approximately 10,900 people.

Bottom Line

Theodore Lundberg's purchase of AdaptHealth Corp. shares is part of a wave of insider buying, suggesting confidence in the company's future. Institutional investors have also been active, increasing their stakes in the company. Analysts remain optimistic, maintaining 'buy' ratings and setting price targets above the current trading level. As always, it's important to remember that insider and institutional transactions are backward-looking indicators and may not reflect current positions.